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Neuroprotective effects of arbutin against oxygen and glucose 
deprivation-induced oxidative stress and neuroinflammation 
in rat cortical neurons
In this study, the neuroprotective potential of arbutin (100 
µmol L–1) pre-treatment and post-treatment against  oxygen/
glucose deprivation (OGD) and reoxygenation (R) induced 
ischemic injury in cultured rat cortical neurons was 
 explored. The OGD (60 min) and reoxygenation (24 h) 
 treatment significantly (p < 0.001) compromised the 
 antioxidant defence in cultured neurons. Subsequently, an 
 increase (p < 0.001) in lipid peroxidation and inflammatory 
cytokines (tumour necrosis factor-α and nuclear factor 
kappa-B) declined neuron survival. In pre- and post-condi-
tion experiments, treatment with arbutin enhanced both 
survival (p < 0.01) and integrity (p < 0.05) of cultured  neurons. 
Results showed that arbutin protects (p < 0.05) against 
 peroxidative changes, inflammation, and enhanced the 
 antioxidant activity (e.g., glutathione, superoxide dismutase 
and catalase) in cultured neurons subjected to OGD/R. It 
can be inferred that arbutin could protect against ischemic 
injuries and stroke. The anti-ischemic activity of arbutin 
can arrest post-stroke damage to the brain.
Keywords: arbutin, cerebral ischemia, inflammation, oxidative 
stress
Oxidative stress and underlying neuroinflammation increase the risk of cerebral isch-
emia manyfold (1). Reactive oxygen species (ROS) and reactive nitrogen species (RNS) can 
modify protein structure resulting in vascular remodelling and neuronal injury (2, 3). 
Peroxidation of lipids gives rise to highly reactive aldehydes that form neurotoxic aggre-
gates with biological substrates such as advanced-glycation end products, DNA, and methyl-
glyoxal (3). Free radicals enhance the preponderance of ischemic attack and are also impli-
cated in post-ischemia complications (4, 5). Under ischemic conditions, excessive excitatory 
signals in the brain intensify redox-imbalance and intracellular calcium overload that 
impedes aerobic respiration and ATP formation. Lack of blood supply creates an ischemic 
zone populated by pro-inflammatory cytokines, adhesion factors, neutrophils, macro-
phages, and lymphocytes (3, 4). Furthermore, upregulation of transcription activity of 
JINGJING TAN1 
MANOJ KUMAR YADAV2 
SUSHMA DEVI2 
MANISH KUMAR2,3*
1 Department of Anesthesia and 
Perioperative Medicine, Shanghai Fourth 
People’s Hospital, Affiliated to Tongji 
University, Shanghai 200081 China
2 Department of Pharmacology, Swift 
School of Pharmacy, Ghaggar Sarai 
Rajpura (Patiala) Punjab – 140401, India
3 Chitkara College of Pharmacy, Chitkara 
University, Rajpura (Patiala) Punjab 
– 140401, India
 
Accepted January 13, 2021 
Published online February 15, 2021
* Correspondence; e-mail: mkpharmacology@gmail.com
124
J. Tan et al.: Neuroprotective effects of arbutin against oxygen and glucose deprivation-induced oxidative stress and neuroinflammation 
in rat cortical neurons, Acta Pharm. 72 (2022) 123–134.
 
nuclear factor kappa-B (NFκB) augments the expression of inflammatory genes and encod-
ing of cytokines and chemokines (6). These sequences of events lead to hemodynamic 
disturbances that precede an ischemic attack. Within a few hours after ischemia, pro-inflam-
matory cytokines instigate the expression of chemotactic factors that further aggravate the 
brain injury (7). Brain autopsy of ischemic patients revealed a pathogenic increase in 
 pro-inflammatory cytokines such as tumour necrosis factor-α (TNF-α) and chemokines 
(8). Several lines of evidence indicate that phytoproducts might avert or even modify the 
pathogenesis of cerebral ischemic injury (2).
Arbutin (4-hydroxyphenyl-β-D-glucopyranoside) is a natural hydroquinone abun-
dantly present in plants like Origanum majorana (Lamiaceae), Arctostaphylos uva-ursi (Erica-
ceae), Pyrus communis (Rosaceae) and Bergenia crassifolia (Saxifragaceae) (9). Earlier findings 
support antihypertensive, antidiabetic, antiseizure, antimicrobial, gastroprotective, hepato-
protective, and antihyperlipidaemic properties of arbutin (10–14). Arbutin inhibits several 
enzymes (e.g., tyrosinase, α-amylase and α-glucosidase), free radicals, and downregulates 
the transcription of many pro-inflammatory cytokines (10, 15). Previous studies indicated 
improvement in motor-functions and behavioural parameters by arbutin that emphasized 
its neuroprotective action (16–18). Experimental evidence shows that arbutin can alleviate 
the excitotoxic and autophagic mechanisms of neurodegeneration (14, 17). However, there 
is a need to explore the neuroprotective potential of arbutin to sufficient depth. In the present 




Arbutin (purity > 98 %) was procured from Sigma-Aldrich (USA) and prepared in 0.01 % 
dimethylsulfoxide (DMSO) (Himedia, India). Dulbecco’s Modified Eagle’s medium (DMEM), 
ethylenediaminetetraacetic acid (EDTA), foetal bovine serum (FBS), hydrogen peroxide, 
3-(4,5-dimethylthiazole-2-yl)-2,5-dipenyltetrazolium bromide (MTT), nicotinamide adenine 
dinucleotide (NAD+ and NADH) and trypsin were from Himedia; 5,5′-dithio-bis-2-nitro-
benzoic acid (DTNB), glacial metaphosphoric acid, disodium hydrogen phosphate, manganese 
chloride (MnCl2) and 2-mercaptoethanol were from SRL (India). Thiobarbituric acid (TBA) and 
trichloroacetic acid (TCA) were procured from Loba Chemie (India).
Animals and primary cortical neurons culture
Forty Wistar rats (either sex, days 0–1, weight range 7–9 g) were used in this study. The 
guidelines provided by the Committee for the Purpose of Control and Supervision of Expe-
riments on Animals (CPCSEA), New Delhi (India), were followed. The research protocol was 
duly approved by the institutional animal ethics committee (IAEC). The rat pups were 
 euthanized and brains were harvested in a sterile environment. After separation of the 
 meninges, the cortex was isolated and rinsed with sterile phosphate buffer saline (PBS, pH 7.4). 
The cortical tissue was pulverized into smaller sizes, triturated and digested with 0.25 % 
trypsin for 20 min at 37 °C, which was then inactivated by 10 % decomplemented foetal 
bovine serum (FBS). The mixture was triturated through a pipette to make a homogenous 
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preparation, filtered through 70-µm sterilized filters and the filtrate was centrifuged (CPR-30 
Remi Compufuge, Vasai, India) for 10 min at 300×g. The sediment was washed once with PBS 
and suspended in the plating medium, DMEM, containing 0.225 % sodium bicarbonate, 
1 mmol L–1 sodium pyruvate, 2 mmol L–1 L-glutamine, 0.1 % dextrose, 100 U mL–1 penicillin, 
0.1 mg mL–1 streptomycin and 5 % FBS. The pellet was washed twice in this medium. 
 Neurons are then plated on poly-L-lysine pre-coated plates or glass coverslips at the density 
of 2 × 106 cells cm–2. Neurons are grown in a plating medium consisting of 89 % high-glucose 
DMEM, 10 % foetal bovine serum, 100 U mL–1 penicillin, 0.1 mg mL–1 of streptomycin. After 
24 h, the medium was changed to a fresh neurobasal medium supplemented with 2 % B27 
(neuron supplement, Invitrogen, Thermo Fisher Scientific, USA) and 100 U mL–1 penicillin, 
0.1 mg mL–1 of streptomycin, and then refreshed every 2–3 days. Cultures were incubated at 
37 °C in a 95 % air/5 % CO2 in a humidified incubator. Experiments were performed at 5–7 
days of neuron culture growth in vitro (19, 20).
Oxygen-glucose deprivation (OGD) and arbutin treatment
The culture medium was changed to glucose-free DMEM in order to deprive the rat 
cortical neurons of O2 and glucose (OGD). The cultured neurons were washed twice with 
glucose-free DMEM, and thereafter incubated in a hypoxic chamber at 37 °C for 1 h, equili-
brated with 94 % N2, 1 % O2 and 5 % CO2. After completion of 1-h OGD, the medium was 
Fig. 1. Experimental protocol used in the present study. In the precondition experiment, cultured rat corti-
cal neurons were pre-treated with the dimethylsulfoxide (DMSO) vehicle or arbutin (100 µmol L–1) for 
24 h followed or not by oxygen and glucose deprivation (OGD) and reoxygenation (R). In the post-
condition experiment, rat primary neurons were subjected to OGD in a glucose-free medium, and, 
thereafter, treated with vehicle or arbutin (100 µmol L–1) before reoxygenation.
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replaced with neurobasal medium supplemented with 2 % B27 and neurons were incu-
bated for 24 h under normoxic conditions (95 % air and 5 % CO2 at 37 °C). For measure-
ments of MTT and enzyme activity, rat cortical neurons were cultured in a neurobasal 
medium supplemented with 2 % B27, 100 U mL–1 penicillin and 0.1 mg mL–1 streptomycin 
(21, 22). A total of eight groups (n = 5 in each group) were undertaken for pre- and post-
conditioning experiments (Fig. 1). For control experiments, the neuron cultures were sub-
jected to identical conditions and treated with either 0.01 % DMSO vehicle (control) or  arbutin 
(100 µmol L–1) (control arbutin) for 24 h, except 60 min of OGD and 24 h of reoxygenation 
(R) (OGD/R). OGD/R+vehicle group was treated with 0.01 % DMSO for 24 h before OGD/R 
(pre-condition experiment) or immediately after OGD before reoxygenation (post-condi-
tion experiment). OGD/R+arbutin group was treated with arbutin (100 µmol L–1) for 24 h 
before OGD/R (pre-condition experiment) or immediately after OGD before reoxygenation 
(post-condition experiment) (23).
Cell viability assay
The viability of cells is examined by 3-(4,5-dimethylthiazole-2-yl)-2,5-dipenyltetrazo-
lium bromide (MTT) assay. This test determines the metabolically active mitochondria in 
the cells. Cells were seeded in 96-well plates at 5 × 103 cells per 100 µL. After 5 days of 
growth, cells were subjected to OGD and reoxygenation, with arbutin added into the medium. 
After 24 h of reoxygenation, MTT (yellow color salt) was added (2 mL) to the cells at the 
final concentration of 0.5 mg mL–1 and the plates were incubated for 24 h at 37 °C. During 
incubation, living cells converted (via mitochondrial dehydrogenase) the tetrazolium com-
ponent of the dye solution into a formazan product (purple color). The insoluble formazan 
product was then precipitated by centrifugation, the supernatant is removed and 150 µL 
DMSO is added for 20 min to solubilize the formazan product. Absorbance which is 
 directly proportional to the number of surviving cells is measured on a microplate reader 
(Bio-Rad, USA) at 570 nm (24).
Cell injury assay
Cell injury is detected by measuring lactate dehydrogenase (LDH). The assay is based 
on the reduction of NAD+ by LDH. The resulting NADH is utilized in the stoichiometric 
conversion of a tetrazolium dye. LDH release is measured in the culture medium using the 
LDH assay kit (Sigma-Aldrich). Culture medium (100 µL) is transferred from culture wells 
to 96-well plates and mixed with the 100 µL reaction solution provided in the kit. Absor-
bance is measured at 490 nm 30 min later using a microplate reader (25). The background 
absorbance of the multi-well plates measured at 690 nm is subtracted.
Oxidative stress
The cultured neurons were harvested, sonicated for 3 min in an ice-cold water bath, 
proteins were precipitated with 4.5 % trichloroacetic acid (TCA) and centrifuged (10 min 
at 3000×g, 4 °C) to collect the supernatant. Lipid peroxidation was calculated using the 
TBARS (thiobarbiturate reactive substances) assay. Quantification of TBARS corresponds 
to the MDA level that shows the extent of lipid peroxidation. Briefly, the assay mixture 
consisted of 1 mL above prepared supernatant, TCA (20 %, 1.5 mL), 1 mL of freshly  prepared 
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TBA (0.67 %) and absorbance was read at 535 nm. Lipid peroxidation values were expressed 
as nmol TBARS mg–1 protein (26, 27).
For reduced glutathione (GSH) assay, the mixture  consisted of 5,5′-dithio-bis-2-nitro-
benzoic acid (DNTB) (0.4 % in 1 % sodium citrate) and double-distilled water. Absorbance 
was read at 412 nm against a blank. Values were expressed as micromoles of reduced 
glutathione per mg protein (26).
For reduced glutathione (GSH) assay, the mixture consisted of 0.3 mL supernatant, 
2 mL Na2HPO4 (0.3 mol L–1), 0.25 mL of 5,5′-dithio-bis-2-nitrobenzoic acid (DNTB) (0.4 % in 
1 % sodium citrate) and double-distilled water. Absorbance was read at 412 nm against a 
blank. Values were expressed as micromoles of reduced glutathione per mg protein (26).
For catalase (CAT) assay, the reaction mixture consisted of 20 µL supernatant, 1.2 mL 
of H2O2 (10 mmol L–1) and 50 mmol L–1 PBS (pH 7.0). The decrease in absorbance was 
noted at 240 nm for 5 min. One unit of CAT activity was defined as one micromole of 
H2O2 decomposed per minute at 25 °C using the molar absorption coefficient of H2O2 
(43.6 L mol–1 cm–1 at λmax = 240 nm). The results were expressed as CAT U mg–1 protein (28).
To determine the superoxide dismutase (SOD) activity, a decrease of absorbance was 
measured using the microplate reader (and UV plates) at 340 nm in a reaction mixture 
containing 3 mmol L–1 NADH, 25 mmol L–1/12.5 mmol L–1 EDTA/MnCl2, 10 mmol L–1 
2-mercaptoethanol, and 50 mL of the cell lysate in 300 mL of triethanolamine-diethanol-
amine buffer (pH 7.4), after 20 min. One SOD activity unit is defined as the amount of SOD 
capable of inhibiting 50 % rate of NADH oxidation observed in the control. The results 
were expressed as SOD U mg–1 protein (28).
TNF-α and NFκB
Double antibody sandwich ELISA was used to determine the nuclear factor kappa-B 
(NFκB) and tumor necrosis factor (TNF-α) levels. Standard methods provided in kits of 
TNF-α (Krishgen Biosystems, India) and NFκB (KinesisDx, USA) were followed. The soni-
cated culture sample was centrifuged at 2500×g for 20 min and the supernatant was used 
for the estimation of NFκB and TNF-α content. This supernatant was added to rat mono-
clonal antibody pre-coated wells (96 wells) and treated with secondary antibodies labeled 
with biotin followed by incubation for 1.5 h (37 °C). Afterward, streptavidin-horseradish 
peroxidase was added to the wells and again incubated at 37 °C for 1 h after covering the 
plate. After incubation, chromogenic solution A and B or TMB substrate was added that 
produced bluish color. A stop solution was added to stop the reaction and absorbance was 
noted at 450 nm (λmax) in ELISA microplate reader (iMARK, Bio-Rad, USA) within 15 min 
after the reaction has been stopped. The concentration of NFκB and TNF-α in an unknown 
sample was calculated from the standard curve. The amount of NFκB is expressed in ng 
mL–1 and TNF-α level in pg mL–1.
Statistical analysis
All the data are expressed as mean ± standard error of the mean (SEM). Statistical dif-
ferences between the groups were assessed with a one-way ANOVA followed by Tukey’s 
post-hoc test. A value of p < 0.05 is considered statistically significant.
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RESULTS AND DISCUSSION
Arbutin protects neurons against OGD triggered injury
In pre-/post-condition paradigms, arbutin treatment in rat cortical culture without 
OGD (control arbutin) showed neuron viability akin to the control neurons that received 
DMSO vehicle only. Exposure to OGD (60 min) and reoxygenation (24 h) decreased the mean 
absorbance (λmax = 570 nm) for MTT that measures cell viability. MTT assay results indicated 
that the viability of cultured rat cortical neurons that were subjected to OGD/R was signifi-
cantly decreased (p < 0.001) in comparison to vehicle-treated controls that were excluded 
from OGD/R treatment in pre- (Fig. 2a) and post-condition paradigms (Fig. 2b). The LDH 
activity was significantly (p < 0.001) enhanced when the cultured neurons were subjected to 
OGD/R in pre- (Fig. 2c) and post-condition experiments (Fig. 2d). These findings showed that 
OGD/R significantly compromised neuron integrity. Interruption of metabolic fuel and oxy-
gen delivery hampers cellular oxidative metabolism and neuron survival. Restoration of 
oxygen supply further perpetuates the injury cascade in neurons (29). In this study, results 
of MTT assay revealed that arbutin (100 µmol L–1) pre-treatment [F(3,19) = 24.33; p < 0.001] or 
post-treatment [F(3,19) = 27.85; p < 0.001] significantly (p < 0.01) enhanced the viability of rat 
primary cortical neurons against OGD/R injury in comparison to neurons subjected to 
OGD/R and vehicle treatments only. Furthermore, a significant decrease (p < 0.05) in the 
LDH activity in response to arbutin pre-treatment [F(3,19) = 16.67; p < 0.001] and post-treat-
Fig. 2. Effects of arbutin on cell viability (MTT assay) and cell death (LDH assay) in rat primary neu-
ron culture in: a) and c) pre- and b) and d) post-condition paradigms. Mean ± SEM (n = 5). Significant 
difference: ***p < 0.001 vs. control group, #p < 0.05, ##p < 0.01 vs. OGD/R+vehicle group.
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Fig. 3. Effects of arbutin on the parameters of oxidative stress in rat primary neuron culture in: a), c), 
e), and g) pre- and b), d) f) and h) post-condition paradigms. Mean ± SEM (n = 5). Significant difference: 
***p < 0.001 vs. control group, #p < 0.05, ##p < 0.01 vs. OGD/R+vehicle group.
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ments [F(3,19) = 19.01; p < 0.001] was observed in the cultured neurons subjected to OGD/R 
injury. In both, pre-/post-condition experiments, the LDH activity of arbutin treated neurons 
and vehicle-treated neurons were found to be similar.
Arbutin reduces the oxidative stress in rat cortical neurons against OGD
Vehicle (control) or arbutin (control arbutin) treated OGD deprived cultured neurons 
showed a similar TBARS content. In both, pre-/post-condition experiments, exposure to 
OGD markedly increased the lipid peroxidation (TBARS) in the rat cortical neurons as 
shown by a significant (p < 0.001) rise in TBARS content in comparison to the control neu-
rons which received DMSO vehicle only. Hypoxia and lack of metabolic fuel (glucose) 
supply trigger ROS that causes aggregation of oxidized lipids. The extent of lipid peroxida-
tion directly correlates with the severity of brain injury and inflammation (30). However, 
treatment of neurons with arbutin (100 µmol L–1) before [F(3,19) = 17.89; p < 0.001] (Fig. 3a) or 
after [F(3,19) = 16.11; p < 0.001] OGD (Fig. 3b) caused a significant (p < 0.05) decrease in the 
TBARS in comparison to the cultured neurons that were subjected to OGD and vehicle 
treatments only.
The endogenous antioxidants (e.g., GSH, catalase and SOD) maintain redox homeostasis 
within neurons by detoxifying several types of free radicals (e.g., ROS, RNS, H2O2) and 
peroxidation products. In previous studies, a conspicuous decrease in sulfhydryl group 
Fig. 4. Effects of arbutin on biomarkers of neuroinflammation (TNF-α and NFκB) in rat primary neu-
ron culture in: a) and c) pre- and b) and d) post-condition paradigms. Mean ± SEM (n = 5). Significant 
difference: *p < 0.05, **p < 0.01 vs. control group, #p < 0.05 vs. OGD/R+vehicle group.
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(-SH) antioxidants has been observed in cerebral ischemia (1, 31). Results of the present 
study revealed analogous antioxidant status (GSH, CAT and SOD) of neuron culture that 
received vehicle (control) or arbutin (control arbutin). Exposure of rat primary neuron cul-
ture to OGD/R caused a marked (p < 0.001) decrease in the GSH content, and CAT and SOD 
activities in comparison to vehicle treated control that were excluded from OGD/R treat-
ment in pre- and post-condition paradigms. However, arbutin (100 µmol L–1) treatment 
before OGD prevented the reduction of GSH (p < 0.01) [F(3,19) = 26.13; p < 0.001] (Fig. 3c), CAT 
(p < 0.01) [F(3,19) = 27.25; p < 0.001] (Fig. 3e) and SOD activity (p < 0.05) [F(3,19) = 16.40; p < 0.001] 
(Fig. 3g) in comparison to the neurons subjected to OGD and vehicle treatments only. 
Further more, post-ischemia arbutin treatment caused a significant rise in the GSH (p < 0.01) 
[F(3,19) = 26.06; p < 0.001] (Fig. 3d), CAT (p < 0.05) [F(3,19) = 18.12; p < 0.001] (Fig. 3f) and SOD 
 activity (p < 0.05) [F(3,19) = 24.61; p < 0.001] (Fig. 3h) in rat cortical neurons compared to  neurons 
that received OGD and vehicle treatments.
Arbutin decreases the inflammation in rat cortical neurons against OGD
In vehicle- or arbutin-treated OGD deprived cultured neurons we observed a similar 
TNF-α and NFκB level. In agreement with previous reports (1, 7), the present findings 
showed that in pre-condition [F(3,19) = 6.166; p < 0.001] (Fig. 4a) and post-condition experi-
ments [F(3,19) = 6.863; p < 0.001] (Fig. 4b), the rat cortical neurons subjected to OGD caused 
marked increase in the TNF-α (p < 0.05) in comparison to the control neurons deprived of 
OGD. The NFκB level was also significantly enhanced (p < 0.01) in cultured neurons exposed 
to OGD in both pre-condition [F(3,19) = 9.575; p < 0.001] (Fig. 4c) and post-condition paradigms 
Fig. 5. Putative neuroprotective mechanism of arbutin against oxygen and glucose deprivation trig-
gered ischemic injury to cultured neurons. 4-HNE – 4-hydroxy 2-nonenal, ATP – adenosine triphos-
phate, CAT – catalase, CBF – cerebral blood flow, GluR – glutamate receptors, GSH – glutathione, 
iNOS – inducible nitric oxide synthase, MDA – malondialdehyde, NFκB – nuclear factor kappa-light-
chain-enhancer of activated B cells, NO – nitric oxide, OGD – oxygen-glucose deprivation, ROS – reac-
tive oxygen species, SOD – superoxide dismutase, TNF-α – tumour necrosis factor-alpha.
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[F(3,19) = 7.564; p < 0.001] (Fig. 4d) when compared with the control neuron culture that were 
excluded from exposure to OGD. NFκB is a transcription factor that upregulates the expres-
sion of inflammatory cytokines (e.g., interleukins, inducible nitric oxide synthase, cyclo- 
oxygenase and TNF-α), apoptotic factors (e.g., Bcl-2) and IκB (6). Hyperactive NFκB is the key 
feature after post-ischemic reperfusion in the brain (31). However, treatment of neurons 
with arbutin before OGD prevented the increase in TNF-α (p < 0.05) and NFκB (p < 0.05) in 
comparison with the vehicle-treated OGD/R neurons. Neuron culture treated with arbutin 
post OGD triggered ischemia showed a significant reduction in TNF-α (p < 0.05) and NFκB 
(p < 0.05) as compared to the neuron culture that was subjected to OGD and vehicle treat-
ments only. Results of the present study showed that treatment of cultured neurons with 
arbutin after or before OGD/R injury significantly attenuated the TNF-α and NFκB expres-
sions. These findings amply indicate the anti-inflammatory activity of arbutin against 
OGD/R triggered ischemic injury in rat primary neuron culture (Fig. 5).
CONCLUSIONS
Exposure of primary neuron culture to OGD/R triggered oxidative stress and neuro-
inflammation while decreasing the neuron viability. Treatment with arbutin before or after 
OGD/R protected the neurons owing to control over oxidized lipids, inflammation, and an 
increase in antioxidants. The present findings indicate that arbutin can prevent the se-
quence of events that lead to ischemia. Furthermore, it can alleviate the progression of the 
neurodegenerative cascade after ischemic injury.
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